Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa

Adalimumab-induced thrombocytopenia is a rarely occurring condition that may present with hemorrhagic manifestations. This report describes a case of a patient who presented with severe, symptomatic thrombocytopenia while on adalimumab for the treatment of hidradenitis suppurativa. The patient respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Tkrit, Amna, Obada, Zaid, Muqeet, Sara, Cervantes, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164782/
https://www.ncbi.nlm.nih.gov/pubmed/34094734
http://dx.doi.org/10.7759/cureus.14769
Descripción
Sumario:Adalimumab-induced thrombocytopenia is a rarely occurring condition that may present with hemorrhagic manifestations. This report describes a case of a patient who presented with severe, symptomatic thrombocytopenia while on adalimumab for the treatment of hidradenitis suppurativa. The patient responded to treatment with steroids, intravenous immunoglobulin (IVIG), and platelet transfusion, in addition to discontinuation of adalimumab.

Ejemplares similares